The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been clearly defined. This procedure carries a mortality rate of approximately 10%. The challenges during pelvic surgery are different between men and women. The morbidity in men with LARC who received pelvic exenteration was analyzed. Medical records of men with LARC undergoing total pelvic exenteration or supralevator pelvic exenteration from January 1991 to December 2007 were retrospectively reviewed. A total of 23 cases were included in the analysis. Thirteen patients had primary cancer, 10 had recurrent cancer. Microscopically clear surgical margins were obtained in 14 patients (60.9%). Sixteen patients (69.6%) experienced major or minor postoperative comp...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
Background Indications for and the prognosis of posterior pelvic exenteration (PPE) in rectal cancer...
Background: The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been cl...
SummaryBackgroundThe role of pelvic exenteration in locally advanced rectal cancer (LARC) has not be...
AIM To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced ...
To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced prim...
Background: Since its first description in 1948, total pelvic exenteration has been a surgical optio...
Aims: To report the role of total pelvic exenteration in a series of locally advanced and recurrent ...
BACKGROUND: Over one-third of primary rectal cancers are locally advanced at diagnosis, and local re...
Background Pelvic exenteration is the only radical treatment for locally advanced (ARC) or recurrent...
Background. Patients with stage T4 rectal cancer are known to have poor survival and often require p...
Between November 1987 and January 1996 pelvic exenteration for primary rectal cancer was carried out...
Primary rectal cancer can recur loco-regionally in the pelvic compartment despite multidisciplinary ...
Background: Despite multimodal therapy 5–15% of patients who undergo resection for advanced rectal...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
Background Indications for and the prognosis of posterior pelvic exenteration (PPE) in rectal cancer...
Background: The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been cl...
SummaryBackgroundThe role of pelvic exenteration in locally advanced rectal cancer (LARC) has not be...
AIM To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced ...
To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced prim...
Background: Since its first description in 1948, total pelvic exenteration has been a surgical optio...
Aims: To report the role of total pelvic exenteration in a series of locally advanced and recurrent ...
BACKGROUND: Over one-third of primary rectal cancers are locally advanced at diagnosis, and local re...
Background Pelvic exenteration is the only radical treatment for locally advanced (ARC) or recurrent...
Background. Patients with stage T4 rectal cancer are known to have poor survival and often require p...
Between November 1987 and January 1996 pelvic exenteration for primary rectal cancer was carried out...
Primary rectal cancer can recur loco-regionally in the pelvic compartment despite multidisciplinary ...
Background: Despite multimodal therapy 5–15% of patients who undergo resection for advanced rectal...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
Background Indications for and the prognosis of posterior pelvic exenteration (PPE) in rectal cancer...